Familial primary pulmonary hypertension
Information
- Disease name
- Familial primary pulmonary hypertension
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03528902 | Completed | Phase 2 | Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension | October 1, 2018 | June 14, 2023 |
| NCT04908397 | Completed | Phase 1 | Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension | September 29, 2021 | June 30, 2023 |
| NCT03683186 | Enrolling by invitation | Phase 3 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | September 23, 2019 | September 2024 |
| NCT03626688 | Recruiting | Phase 3 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | August 30, 2018 | December 2024 |
| NCT04084678 | Terminated | Phase 3 | A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH | January 20, 2021 | April 12, 2023 |
| NCT01645826 | Withdrawn | N/A | Efficacy Study of Cardizem in Pulmonary Arterial Hypertension | July 2012 | September 2014 |
- MedGen concept unique identifier (MedGen Concept name)
- C0340543
- MedGen unique identifier (MedGen Concept name)
- 90953
- MeSH unique ID (MeSH (Medical Subject Headings))
- D065627